TOP STORIES
Healthcare IT News released its EHR satisfaction survey results. The TL;DR version: no one gets higher than a 7.6 out of 10, Epic gets the highest rankings for interoperability, and I found the comments more entertaining than the data.
If these were grades in school with 10 = 100%, all the vendors would have failed except for one and they would only have received a D. What does this tell you? It tells me that these vendors aren’t listening to their customers. Wow, look at the failing customer support numbers. Terrible, terrible, terrible. The CEO’s of these companies are extremely mistaken if they feel they are doing a good job after looking at these kinds of numbers. I’m sure many excuses will be forthcoming, such as blaming the ONC, CMS and others but the blame is squarely on the shoulders of these companies. You’ve enriched yourselves by overcharging for poorly performing systems that still won’t talk to each other well or at all. You’ve all failed in my opinion. Get your collective acts together already. Geez
– Healthcare IT News, Healthcare IT News
Mylan launched its hostile bid for Perrigo. At $27 billion, it’s $8 billion less than what it offered in April (Mylan’s stock has dropped by more than one-third in the last three months). – Wall Street Journal
LIFE SCIENCES
Swiss medical device company Symetis has set its IPO at a minimum of $16.16. – Reuters
A Deep-dive Into Specialty Pharma
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
Terrible news. Cardiovascular Systems CEO David Martin has been diagnosed with stomach cancer. – Star Tribune
Aclaris Therapeutics added $40 million and acquired a set of compounds from Rigel Pharmaceuticals. – Philadelphia Business Journal
FDA has put a hold on Forum Pharmaceuticals’ Alzheimer’s trials after some severe gastrointestinal reactions. – FierceBiotech
Medtronic’s MRI-safe cardiac defibrillator, Evera MRI SureScan, has won FDA approval. – MassDevice
Biopharma Trevena wants to add another $63.4 million through a public stock sale this week. Mirati Therapeutics plans an $80 million sale in about two weeks. – Philadelphia Business Journal, PRNewswire
Here’s a rundown of the new St. Jude Medical management team. – BusinessWire
Physio-Control has purchased Northern Ireland’s HeartSine Technologies, which makes automated external defibrillators. – BusinessWire
Myriad Genetics has a new logo. The rebranding is heavy on the consumer-empowerment angle. What do you think?
PAYERS-PROVIDERS
The new Oregon Center for Health Innovation will study population health innovations, among other things. – Portland Business Journal
Patient engagement on the grassroots level: A doctor goes to the barber shop to improve public health. – Huffington Post
A $200 billion opportunity: the need to refurbish or outright redesign healthcare facilities. – Futurity
Long Shore-Long Island Jewish Health System is now …. Northwell Health. – Newsday
Here’s how population health can better support chronic asthma management. – Brookings
Aspirin gets an early nod as a cancer preventer. – The New York Times
UnitedHealthcare has a new CEO for its New Mexico and Arizona markets: David Allazetta – Phoenix Business Journal
TECH
Japanese startup Moff has raised $1.3 million from video game makers to develop its child-focused wearable. – mobihealthnews
COMS Interactive has upgraded its disease care management system, Daylight IQ. – PRNewswire
POLITICS
The FDA has revamped its foreign office staff, including new directors in China, Europe, India and Latin America. – RAPS
Rhode Island is turning into a cautionary tale against using state dollars to fund early-stage companies. Life science startup Nabsys has shut down and now all hell has broken loose for the state and Gov. Gina Raimondo, who used to run the venture firm that also funded Nabsys. – GoLocalProv, GoLocalProv
A majority of House members have co-sponsored a bill to repeal the Cadillac tax (which means nothing). – PRNewswire
A LITTLE BIT EXTRA
Fascinating data breakdown of corporate venture capital term sheets across all sectors: they lead more rounds than ever before and their terms look more like traditional VC sheets. But, they remain extremely company friendly.
